Adaptive Biotechnologies Corp
ADPT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001478320
In the last 90 days, Adaptive Biotechnologies Corp insiders filed 0 open-market purchases and 20 sales; 305 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; superinvestors Viking Global Investors and ARK Invest hold it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:16 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $59.5M (21.5% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Feb 11, 2025 | Feb 14, 2024 | Feb 14, 2023 | Jan 10, 2022 |
| Revenue | $277.0M | $179.0M | $170.3M | $185.3M | $154.3M |
| Cost of revenue | $71.4M | $72.1M | $75.6M | $57.9M | $49.3M |
| Research and development | $93.8M | $103.0M | $122.1M | $141.8M | $142.3M |
| Selling, general and administrative | $72.7M | $72.8M | $83.9M | $88.5M | $74.5M |
| Operating income | -$57.1M | -$162.5M | -$227.0M | -$200.2M | -$209.0M |
| Interest expense | $11.8M | $11.6M | $13.8M | $4.24M | – |
| Income tax | $0 | – | – | – | – |
| Net income | -$59.5M | -$159.5M | -$225.3M | -$200.2M | -$207.3M |
| EPS, basic | $-0.39 | $-1.08 | $-1.56 | $-1.40 | – |
| EPS, diluted | $-0.39 | $-1.08 | $-1.56 | $-1.40 | – |
| Weighted shares, basic | 151.7M | 147.1M | 144.4M | 142.5M | – |
| Weighted shares, diluted | 151.7M | 147.1M | 144.4M | 142.5M | – |
| Margins and growth | |||||
| Operating margin | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% |
| Net margin | -21.5% | -89.1% | -132.3% | -108.0% | -134.3% |
| Revenue growth, year over year | +54.8% | +5.1% | −8.1% | +20.1% | +56.9% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Feb 11, 2025 | Feb 14, 2024 | Feb 14, 2023 | Jan 10, 2022 |
| Cash and equivalents | $70.5M | $47.9M | $65.1M | $90.0M | $139.1M |
| Accounts receivable | $50.4M | $41.7M | $38.0M | $40.1M | $17.4M |
| Inventory | $9.82M | $8.44M | $14.4M | $14.5M | $19.3M |
| Total current assets | $300.2M | $283.8M | $410.2M | $562.1M | $402.7M |
| Property, plant and equipment | $34.1M | $48.6M | $68.2M | $83.4M | $85.3M |
| Goodwill | $119.0M | $119.0M | $119.0M | $119.0M | $119.0M |
| Intangible assets | $1.73M | $3.42M | $5.13M | $6.83M | $8.53M |
| Total assets | $512.7M | $539.4M | $661.1M | $856.6M | $923.3M |
| Accounts payable | $6.47M | $7.26M | $7.72M | $8.08M | $3.31M |
| Short-term debt | $4.64M | $865.0K | – | – | – |
| Total current liabilities | $89.9M | $98.1M | $88.0M | $109.8M | $113.8M |
| Long-term debt | $126.6M | $132.4M | $130.7M | – | – |
| Total liabilities | $287.7M | $336.9M | $352.9M | $392.5M | $319.2M |
| Shareholders' equity | $225.0M | $202.5M | $308.3M | $464.1M | $604.1M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Feb 11, 2025 | Feb 14, 2024 | Feb 14, 2023 | Jan 10, 2022 |
| Operating cash flow | -$46.0M | -$95.2M | -$156.3M | -$183.9M | -$192.7M |
| Capital expenditures | $2.96M | $3.66M | $10.7M | $16.3M | $61.7M |
| Free cash flow | -$48.9M | -$98.9M | -$167.0M | -$200.3M | -$254.5M |
| Depreciation and amortization | $16.0M | $19.3M | – | – | – |
| Stock-based compensation | $51.5M | $53.6M | $62.9M | $55.5M | $43.3M |
| Investing cash flow | $38.0M | $77.8M | $129.6M | $2.90M | $181.2M |
| Financing cash flow | $30.4M | $241.0K | $2.25M | $132.3M | $27.1M |
| Net change in cash | $22.4M | -$17.2M | -$24.4M | -$48.8M | $15.6M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 18.6% | 30.0% | 36.9% | 29.9% | 28.0% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 30, 2026 | 161.9M | +6.0% | SEC |
| Jul 31, 2026 | 159.6M | +4.8% | SEC |
| Apr 30, 2026 | 160.0M | +5.4% | SEC |
| Feb 20, 2026 | 154.0M | +3.6% | SEC |
| Oct 31, 2025 | 152.7M | +3.4% | SEC |
| Jul 31, 2025 | 152.3M | +3.3% | SEC |
| Apr 24, 2025 | 151.9M | +3.1% | SEC |
| Feb 26, 2025 | 148.6M | +2.4% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.